Amedisys Inc (AMED)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,300 | -24,870 | -1,190 | 10 | 940 |
| Depreciation Amortization | 3,068 | 1,700 | 1,240 | 940 | 640 |
| Accounts receivable | -9,981 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -981 | N/A | N/A | N/A | N/A |
| Other Working Capital | -10,652 | N/A | -3,210 | -2,480 | N/A |
| Other Operating Activity | 5,024 | 30,790 | 2,020 | 600 | -30 |
| Operating Cash Flow | $-12,222 | $7,620 | $-1,140 | $-930 | $1,550 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -829 | N/A | -1,260 | -2,950 | N/A |
| Net Acquisitions | 12,223 | N/A | 0 | 0 | N/A |
| Purchase Of Investment | 81 | N/A | N/A | N/A | N/A |
| Other Investing Activity | 0 | -3,070 | 20 | 240 | -390 |
| Investing Cash Flow | $11,475 | $-3,070 | $-1,240 | $-2,710 | $-390 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 1,383 | N/A | N/A | N/A | N/A |
| Debt Repayment | 1,689 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -1,287 | -8,050 | 5,340 | 3,880 | -420 |
| Financing Cash Flow | $1,785 | $-8,050 | $5,340 | $3,880 | $-420 |
| Beginning Cash Position | 387 | 4,070 | 1,100 | 870 | 140 |
| End Cash Position | 1,425 | 570 | 4,070 | 1,100 | 870 |
| Net Cash Flow | $1,038 | $-3,490 | $2,960 | $230 | $720 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,222 | 7,620 | -1,140 | -930 | 1,550 |
| Capital Expenditure | -947 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -13,169 | 7,620 | -1,140 | -930 | 1,550 |